Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories
Cardiovascular Drugs and Therapy · 17.11.2026
DOI: 10.1007/s10557-026-07990-4 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 17.11.2026. Verfasst von Teruhiko Imamura. Beteiligte Einrichtung: Second Department of Internal Medicine, University of Toyama, 2630 Sugitani Toyama, Toyama, 930-0194, Japan. te.imamu@gmail.com. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Department of Internal Medicine, University of Toyama, 2630 Sugitani Toyama, Toyama, 930-0194, Japan. te.imamu@gmail.com.
ORCID-Profile: Teruhiko Imamura
Zitieren
APA
Imamura, T. (2026). Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-026-07990-4
Vancouver
Imamura T. Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories. Cardiovascular Drugs and Therapy. 2026. doi:10.1007/s10557-026-07990-4
BibTeX
@article{Imamura2026,
author = {Imamura, Teruhiko},
title = {Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories},
journal = {Cardiovascular Drugs and Therapy},
year = {2026},
doi = {10.1007/s10557-026-07990-4}
}
EUVIMED